ISOPP CAPhO 2025 Symposium: Sponsored Lunch Symposium Bristol Myers Squibb MISSION POSCIBLE – Exploring the Role of Subcutaneous Immunotherapy Formulations

In this dynamic and interactive symposium, a multidisciplinary panel of experts will discuss the latest advances in subcutaneous immunotherapy in oncology. Through short presentations of relevant data, panel discussions, interactive polling sessions, and a question-and-answer period, participants will review safety and efficacy data for SC IO formulations, understand their role in the current healthcare environment, and gain practical tips regarding the implementation and administration of these therapeutic options.

Learning objectives

• Evaluate the latest advances in SC IO therapy applications across multiple tumour types
• Understand the potential impact of SC IO therapy in healthcare utilization and services
• Increase expertise in the safe administration of SC oncology drugs in different care settings